These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11906957)

  • 41. The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients.
    Breedveld P; Pluim D; Cipriani G; Wielinga P; van Tellingen O; Schinkel AH; Schellens JH
    Cancer Res; 2005 Apr; 65(7):2577-82. PubMed ID: 15805252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular localization of NKCC2 and its possible role in the Cl- absorption in the rat and human distal colonic epithelia.
    Zhu JX; Xue H; Ji T; Xing Y
    Transl Res; 2011 Sep; 158(3):146-54. PubMed ID: 21867980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.
    Jaquet P; Gunz G; Saveanu A; Barlier A; Dufour H; Taylor J; Dong J; Kim S; Moreau JP; Culler MD
    J Endocrinol Invest; 2005; 28(11 Suppl International):21-7. PubMed ID: 16625841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
    Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, and biological evaluation of novel somatostatin receptor subtype-2 agonists: Optimization for potency and risk mitigation of hERG and phospholipidosis.
    Ishida A; Okabe Y; Matsushita T; Sekiguchi T; Nishio T; Komagata T; Iwaki M; Miyata H; Katagi J; Naganawa A; Maruyama T; Imagawa A
    Bioorg Med Chem; 2021 Nov; 49():116424. PubMed ID: 34626901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptor signaling and endocytosis are differentially regulated by somatostatin analogs.
    Liu Q; Cescato R; Dewi DA; Rivier J; Reubi JC; Schonbrunn A
    Mol Pharmacol; 2005 Jul; 68(1):90-101. PubMed ID: 15855408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colonic submucosal 5-HT(3) receptor-mediated somatostatin-dependent secretoinhibitory pathway is suppressed in water-immersion restraint stressed rats.
    Li Y; Li XF; Hua Guo ; Xu JD; Zhang XH; Li LS; Feng XY; Zhang Y; Duan ZP; Zhu JX
    Eur J Pharmacol; 2011 Apr; 656(1-3):94-100. PubMed ID: 21291881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.
    Bardelmeijer HA; Beijnen JH; Brouwer KR; Rosing H; Nooijen WJ; Schellens JH; van Tellingen O
    Clin Cancer Res; 2000 Nov; 6(11):4416-21. PubMed ID: 11106262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-GLYCOprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar.
    Durmus S; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Mol Pharm; 2012 Nov; 9(11):3236-45. PubMed ID: 23020847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors.
    Streuli J; Harris AG; Cottiny C; Allagnat F; Daly AF; Grouzmann E; Abid K
    Neuropeptides; 2018 Apr; 68():84-89. PubMed ID: 29523357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.
    Wild D; Schmitt JS; Ginj M; Mäcke HR; Bernard BF; Krenning E; De Jong M; Wenger S; Reubi JC
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1338-47. PubMed ID: 12937948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.
    Cervia D; Nunn C; Fehlmann D; Langenegger D; Schuepbach E; Hoyer D
    Br J Pharmacol; 2003 May; 139(1):109-21. PubMed ID: 12746229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin a secretion and on cell viability in human nonfunctioning pituitary adenomas in vitro.
    Zatelli MC; Piccin D; Bottoni A; Ambrosio MR; Margutti A; Padovani R; Scanarini M; Taylor JE; Culler MD; Cavazzini L; degli Uberti EC
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5181-8. PubMed ID: 15472224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rat hippocampal somatostatin sst3 and sst4 receptors mediate anticonvulsive effects in vivo: indications of functional interactions with sst2 receptors.
    Aourz N; De Bundel D; Stragier B; Clinckers R; Portelli J; Michotte Y; Smolders I
    Neuropharmacology; 2011 Dec; 61(8):1327-33. PubMed ID: 21854790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors.
    Schmid HA; Lambertini C; van Vugt HH; Barzaghi-Rinaudo P; Schäfer J; Hillenbrand R; Sailer AW; Kaufmann M; Nuciforo P
    Neuroendocrinology; 2012; 95(3):232-47. PubMed ID: 22156600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanically evoked reflex electrogenic chloride secretion in rat distal colon is triggered by endogenous nucleotides acting at P2Y1, P2Y2, and P2Y4 receptors.
    Christofi FL; Wunderlich J; Yu JG; Wang YZ; Xue J; Guzman J; Javed N; Cooke H
    J Comp Neurol; 2004 Jan; 469(1):16-36. PubMed ID: 14689471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PET study on mice bearing human colon adenocarcinoma cells using [11C]GF120918, a dual radioligand for P-glycoprotein and breast cancer resistance protein.
    Yamasaki T; Kawamura K; Hatori A; Yui J; Yanamoto K; Yoshida Y; Ogawa M; Nengaki N; Wakisaka H; Fukumura T; Zhang MR
    Nucl Med Commun; 2010 Nov; 31(11):985-93. PubMed ID: 20859232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2.
    Yang L; Berk SC; Rohrer SP; Mosley RT; Guo L; Underwood DJ; Arison BH; Birzin ET; Hayes EC; Mitra SW; Parmar RM; Cheng K; Wu TJ; Butler BS; Foor F; Pasternak A; Pan Y; Silva M; Freidinger RM; Smith RG; Chapman K; Schaeffer JM; Patchett AA
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10836-41. PubMed ID: 9724791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptides of human immunodeficiency virus (HIV) evoke rat colonic electrolyte secretion inhibitable by the somatostatin analog octreotide.
    Fassler JE; O'Dorisio TM; Goddard CG; Gaginella TS
    Life Sci; 1991; 48(4):PL13-7. PubMed ID: 1990229
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of the function of TRPV1-expressing nociceptive sensory neurons by somatostatin 4 receptor agonism: mechanism and therapeutical implications.
    Szolcsányi J; Pintér E; Helyes Z; Petho G
    Curr Top Med Chem; 2011; 11(17):2253-63. PubMed ID: 21671870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.